#1
#1 out of 1100.00%
health3h ago
Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say
- MW150, an investigational dementia drug, may reduce brain inflammation linked to alcohol withdrawal.
- The study used cell culture and animal models to assess MW150's anti-inflammatory effects.
- Researchers say follow-up animal studies are needed to confirm systemic health impacts.
- Detoxification remains essential, but additional medications may improve engagement in treatment.
- MW150 could potentially be repurposed for alcohol-related conditions if future studies continue to show promise.
- The study notes MW150 is not yet approved for dementia or alcohol use disorder.
- Experts say reducing neuroinflammation could help patients engage in early treatment.
- The research emphasized the need for more studies before clinical use.
- The study was published in the journal Alcohol and led by Linda Van Eldik.
- The research acknowledges limitations of dish- and animal-based models.
Vote 0